These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27574879)

  • 1. Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review.
    Paracha N; Thuresson PO; Moreno SG; MacGilchrist KS
    Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):549-559. PubMed ID: 27574879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients.
    Paracha N; Abdulla A; MacGilchrist KS
    Health Qual Life Outcomes; 2018 Sep; 16(1):179. PubMed ID: 30208899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regression.
    Wang Y; Gavan SP; Steinke D; Cheung KL; Chen LC
    Health Qual Life Outcomes; 2022 Dec; 20(1):169. PubMed ID: 36564800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB).
    Xie F; Zoratti M; Chan K; Husereau D; Krahn M; Levine O; Clifford T; Schunemann H; Guyatt G
    Med Decis Making; 2019 May; 39(4):370-378. PubMed ID: 30902030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses.
    Nerich V; Saing S; Gamper EM; Holzner B; Pivot X; Viney R; Kemmler G
    Breast Cancer Res Treat; 2017 Aug; 164(3):527-536. PubMed ID: 28497177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results.
    Han R; François C; Toumi M
    Appl Health Econ Health Policy; 2021 Jan; 19(1):29-44. PubMed ID: 32661846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic literature review of health state utility values in head and neck cancer.
    Meregaglia M; Cairns J
    Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health state utility values by cancer stage: a systematic literature review.
    Pourrahmat MM; Kim A; Kansal AR; Hux M; Pushkarna D; Fazeli MS; Chung KC
    Eur J Health Econ; 2021 Nov; 22(8):1275-1288. PubMed ID: 34125315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic searching and selection of health state utility values from the literature.
    Papaioannou D; Brazier J; Paisley S
    Value Health; 2013 Jun; 16(4):686-95. PubMed ID: 23796303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health state utility values among children and adolescents with disabilities: protocol for a systematic review.
    Kanya L; Anokye N; Ryan JM
    BMJ Open; 2018 Feb; 8(2):e019978. PubMed ID: 29467137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of health state utility values in Thai cancer patients.
    Kangwanrattanakul K
    Expert Rev Pharmacoecon Outcomes Res; 2022 Dec; 22(8):1171-1186. PubMed ID: 36084926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-state utility values in breast cancer.
    Peasgood T; Ward SE; Brazier J
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):553-66. PubMed ID: 20950071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review.
    Brockbank J; Krause T; Moss E; Pedersen AM; Mørup MF; Ahdesmäki O; Vaughan J; Brodtkorb TH
    Health Qual Life Outcomes; 2021 Mar; 19(1):94. PubMed ID: 33736649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung Cancer.
    Blom EF; Haaf KT; de Koning HJ
    Pharmacoeconomics; 2020 Nov; 38(11):1187-1200. PubMed ID: 32754857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of health state utility values for acute myeloid leukemia.
    Forsythe A; Brandt PS; Dolph M; Patel S; Rabe APJ; Tremblay G
    Clinicoecon Outcomes Res; 2018; 10():83-92. PubMed ID: 29416365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review.
    Carter GC; King DT; Hess LM; Mitchell SA; Taipale KL; Kiiskinen U; Rajan N; Novick D; Liepa AM
    J Med Econ; 2015; 18(11):954-66. PubMed ID: 26212479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EQ-5D-Derived Health State Utility Values in Hematologic Malignancies: A Catalog of 796 Utilities Based on a Systematic Review.
    Golicki D; Jaśkowiak K; Wójcik A; Młyńczak K; Dobrowolska I; Gawrońska A; Basak G; Snarski E; Hołownia-Voloskova M; Jakubczyk M; Niewada M
    Value Health; 2020 Jul; 23(7):953-968. PubMed ID: 32762998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility values associated with advanced or metastatic non-small cell lung cancer: data needs for economic modeling.
    Brown J; Cook K; Adamski K; Lau J; Bargo D; Breen S; Chawla A
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):153-164. PubMed ID: 28335636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health state utility values for diabetic retinopathy: protocol for a systematic review and meta-analysis.
    Sampson CJ; Tosh JC; Cheyne CP; Broadbent D; James M
    Syst Rev; 2015 Feb; 4():15. PubMed ID: 25875206
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.